Cargando…
Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
The expression of O-GlcNAc transferase (OGT) and its catalytic product, O-GlcNAcylation (O-GlcNAc), are elevated in many types of cancers, including prostate cancer (PC). Inhibition of OGT serves as a potential strategy for PC treatment alone or combinational therapy. PC is the second common cancer...
Autores principales: | Xia, Mingyue, Wang, Shuyan, Qi, Yannan, Long, Kaili, Li, Enjie, He, Lingfeng, Pan, Feiyan, Guo, Zhigang, Hu, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686342/ https://www.ncbi.nlm.nih.gov/pubmed/36439421 http://dx.doi.org/10.3389/fonc.2022.993243 |
Ejemplares similares
-
Corrigendum: Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2023) -
X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body
por: Olivier-Van Stichelen, Stéphanie, et al.
Publicado: (2014) -
Feedback Regulation of O-GlcNAc Transferase through Translation Control to Maintain Intracellular O-GlcNAc Homeostasis
por: Lin, Chia-Hung, et al.
Publicado: (2021) -
Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes
por: Kapuria, Vaibhav, et al.
Publicado: (2016) -
A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis
por: Park, Sung-Kyun, et al.
Publicado: (2017)